Presentations by precision medicine startups and growth stage companies across diagnostics, biopharma and medtech. Their technologies include:
- Genotype-based opioid risk prediction
- Early identification of risks and individualized interventions
- Implantable brain stimulation to treat memory loss
- Identify novel drug targets for chronic pain
- Wireless drug delivery
The presenting companies include:
- Prenome
- Nia Therapeutics
- Doloromics
- SmartTab
- OpalGenix
The judges are:
- Adam Dakin, Managing Director, Dreamit Ventures
- Yizhen Dong, Partner, Global Founders Capital
- Ben Johnson, Managing Director, Head of Early Stage Life Science, Silicon Valley Bank
